摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2,4-trimethyl-6-phenoxy-1,2-dihydroquinoline | 115786-11-3

中文名称
——
中文别名
——
英文名称
2,2,4-trimethyl-6-phenoxy-1,2-dihydroquinoline
英文别名
2,2,4-trimethyl-6-phenoxy-1H-quinoline
2,2,4-trimethyl-6-phenoxy-1,2-dihydroquinoline化学式
CAS
115786-11-3
化学式
C18H19NO
mdl
——
分子量
265.355
InChiKey
LUSPQQMXRZCBGF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    4-氨基二苯醚 以 N-(6,7-dibutoxy-4-methyl-2-quinazolinyl)guanidine 为溶剂, 以10%的产率得到2,2,4-trimethyl-6-phenoxy-1,2-dihydroquinoline
    参考文献:
    名称:
    Compounds for the treatment of pain
    摘要:
    这项发明提供了治疗疼痛、尿失禁和其他由NPFF受体介导的异常的方法,包括向受试者施用在NPFF1受体、NPFF2受体或同时在NPFF1和NPFF2受体上起作用的化学化合物的治疗有效量。
    公开号:
    US20030176314A1
点击查看最新优质反应信息

文献信息

  • Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors
    申请人:——
    公开号:US20030139431A1
    公开(公告)日:2003-07-24
    This invention provides compounds having the structure: 1 wherein X=CH, C(CH 3 ) or N; each of R 1 , R 2 , R 3 , R 4 and R 5 is independently H, C 1 -C 10 straight chained or branched alkyl, C 2 -C 10 straight chained or branched alkenyl, C 2 -C 10 straight chained or branched alkynyl, C 3 -C 10 cycloalkyl, substituted or unsubstituted aryl, hydroxy, halogenated ether, nitro, amino, halogen, —CN, —C(═Z)R 6 , —C(═Z)OR 6 , —C(═Z)N(R 6 ) 2 , —N(R 6 )—C(═Z)R 6 , —N(R 6 )—C(═Z)N(R 6 ) 2 , —OC(═Z)R 6 , —C(═Z)OR 6 —OR 6 or —SR 6 ; wherein Z is O or S; and wherein R 6 is C 1 -C 10 straight chained or branched alkyl, aryl, (CH 2 ) n Q, C 2 -C 10 alkenyl, C 3 -C 10 cycloalkyl, C 5 -C 10 cycloalkenyl, wherein Q is OR 7 , SR 7 , N(R 7 ) 2 or aryl, wherein R 7 is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, wherein R 2 and R 3 and the carbons to which they are attached form a fused aryl, heteroaryl, C 5 -C 10 cyclic alkyl or heterocyclic alkyl ring; or wherein R 3 and R 4 and the carbons to which they are attached form a fused aryl, heteroaryl, cyclic alkyl or heterocyclic alkyl ring; and wherein each alkyl, alkenyl, alkynyl and alkoxy group is optionally substituted with a substituent independently selected from R a , where R a is 1) hydroxy, 2) C 1 -C 10 alkoxy, 3) halogen, 4) nitro, 5) amino, 6) CF 3 , or 7) carboxy, and each cycloalkyl group is optionally substituted with a substituent independently selected from R b , where R b is 1) a group selected from R a , 2) C 1 -C 7 alkyl, 3) C 2 -C 7 alkenyl, 4) C 2 -C 7 alkynyl or 5) cyclic C 1 -C 10 alkyl, and each aryl is optionally substituted with R 1 . This invention also provides methods of treating pain, urge incontinence; as well as methods of preparing the compounds.
    这项发明提供了具有以下结构的化合物:其中 X==CH,C(CH3)或N;R1、R2、R3、R4和R5中的每一个独立地是H、C1-C10直链或支链烷基、C2-C10直链或支链烯基、C2-C10直链或支链炔基、C3-C10环烷基、取代或未取代芳基、羟基、卤代醚、硝基、氨基、卤素、—CN、—C(═Z)R6、—C(═Z)OR6、—C(═Z)N(R6)2、—N(R6)—C(═Z)R6、—N(R6)—C(═Z)N(R6)2、—OC(═Z)R6、—C(═Z)OR6—OR6或—SR6;其中 Z 是 O 或 S;且其中 R6 是 C1-C10直链或支链烷基、芳基、(CH2)nQ、C2-C10烯基、C3-C10环烷基、C5-C10环烯基,其中 Q 是OR7、SR7、N(R7)2或芳基,其中 R7 是H、烷基、烯基、炔基、环烷基、环烯基、芳基,其中 R2、R3和它们连接的碳形成融合芳基、杂芳基、C5-C10环烷基或杂环烷基环;或其中 R3、R4和它们连接的碳形成融合芳基、杂芳基、环烷基或杂环烷基环;以及每个烷基、烯基、炔基和烷氧基组分可以选择性地取代一个从 Ra 中独立选择的取代基,其中 Ra 是 1) 羟基,2) C1-C10烷氧基,3) 卤素,4) 硝基,5) 氨基,6) CF3,或 7) 羧基,每个环烷基组分可以选择性地取代一个从 Rb 中独立选择的取代基,其中 Rb 是 1) 从 Ra 中选择的一组,2) C1-C7烷基,3) C2-C7烯基,4) C2-C7炔基或 5) 环状 C1-C10 烷基,每个芳基可以选择性地取代为 R1。这项发明还提供了治疗疼痛、尿急失禁的方法;以及制备这些化合物的方法。
  • [EN] COMPOSITIONS AND METHODS RELATING TO HIV PROTEASE INHIBITION<br/>[FR] COMPOSITIONS ET PROCÉDÉS LIÉS À L'INHIBITION DE LA VIH PROTÉASE
    申请人:UNIV MICHIGAN
    公开号:WO2009036341A2
    公开(公告)日:2009-03-19
    The present invention relates to HIV protease, and methods for inhibiting the function of HIV protease. In particular, present invention provides compounds that inhibit or block the biological activity of HIVp, thereby causing the replication of the HIV virus to be inhibited or to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS. The compounds and formulations also find use in diagnostic and research settings.
  • Compounds for the treatment of pain
    申请人:——
    公开号:US20030176314A1
    公开(公告)日:2003-09-18
    This invention provides methods of treating pain, urinary incontinence and other abnormalities mediated by a NPFF receptor, which comprises administering to a subject a therapeutically effective amount of a chemical compound which acts at the NPFF1 receptor, the NPFF2 receptor, or at both the NPFF1 and NPFF2 receptors.
    这项发明提供了治疗疼痛、尿失禁和其他由NPFF受体介导的异常的方法,包括向受试者施用在NPFF1受体、NPFF2受体或同时在NPFF1和NPFF2受体上起作用的化学化合物的治疗有效量。
查看更多